MedTrace Logo

Trial of Tang-min-ling Pills in the Treatment of Type 2 Diabetes

NCT01107171 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 210

Last updated 2010-04-21

No results posted yet for this study

Summary

Tang-min-ling pills are made by Chinese herbs extract, and data showed they had antidiabetic effects on the experimental rats and no obvious toxicity was found.This is a randomized, doubled blind, dose-paralleled-control multi-centre clinical trial to evaluate the efficacy and safety of Tang-min-ling pills in the treatment of type 2 diabetic patients and explore the optimal dosage of Tang-min-ling pills.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

DRUG

Tang-min-ling pills low dosage

low dosage:6g Tang-min-ling pills every time,by 3 times every day for 12 weeks.

DRUG

Tang-min-ling pills high dosage

high dosage:12g Tang-min-ling pills every time,by 3 times every day for 12 weeks.

DRUG

Placebo

Tang-min-Ling pills analogue 6g,tid,po

Sponsors & Collaborators

  • Tasly Pharmaceuticals, Inc.

    collaborator INDUSTRY

  • Guang'anmen Hospital of China Academy of Chinese Medical Sciences

    lead OTHER

Principal Investigators

  • Xiaolin Tong, Ph.D · Guang Anmen Hospital of China Academy of Chinese Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2008-12-31
Completion
2008-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01107171 on ClinicalTrials.gov